Stephenson Harwood advises Kaya Limited on the divestment of its Middle East businesses
Law firm Stephenson Harwood LLP has advised Kaya Limited ('Kaya'), an Indian multinational skincare, haircare, and bodycare treatment provider, on the divestment of its Middle East businesses to Humania GCC Holding Limited.
Founded in 2003, Kaya is a publicly listed company with extensive operations in India and is the largest international chain of skincare clinics in the Middle East with a presence across the United Arab Emirates, Kingdom of Saudi Arabia, and the Sultanate of Oman, spread across nine cities throughout the region.
The sale of its Middle East businesses - Kaya Middle East DMCC and Kaya Middle East FZE - to Humania GCC Holding Limited, an investment platform dedicated to healthcare opportunities in the Middle East and emerging markets, is set to bring new growth opportunities for the entities in the region.
The Stephenson Harwood team advised on all aspects of the transaction including the drafting and negotiation of the transaction documents.
"I am pleased that the team and I were able to assist Kaya on such a strategic mandate closely aligned to their business objectives," said Dubai-based corporate and commercial Partner Diwakar Agarwal. "The transaction was a complex cross-border M&A matter, which demonstrates the firm's ability to act as international counsel across multiple jurisdictions within the MENA market, as well as successfully leveraging our in-depth life sciences and healthcare industry knowledge."
分享文章
相关专业知识
相关文章
Minibonds - still a problem, or problem solved?
Stephenson Harwood strengthens its Private Wealth Disputes practice with the arrival of Partner Laura Hasson
Stephenson harwood strengthens Singapore Finance practice with addition of Zhi Chao Chor
Stephenson Harwood advises Lactalis on acquisition of Saputo's UK Dairy Division
The UK Market Abuse Regime for Cryptoassets (“MARC”) – the FCA’s final rules
Media article: Lessons from recent aviation restructurings
Sanctions, export controls and other trade restrictions: Overcompliance in a conflict-of-laws era- why "when in doubt, don't perform" may no longer be the safest strategy